IP Library Granted Patent US 8,835,126
Granted Patent B2
US 8,835,126 · App. 13/161,114 · Granted Sep 16, 2014

Tritiated planar carbon forms

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,835,126
App. No.
13/161,114
Granted
Sep 16, 2014
Kind
B2
Abstract

Tritiated planar carbon forms and their production are provided. Methods are provided for the stoichiometrically controlled labeling of planar carbon forms capitalizing on normal flaws of carboxylic acids ubiquitously present in commercial preparations of these planar carbon forms. Alternative methods include generation of a metallated intermediate whereby a metal is substituted for hydrogen on the carbon backbone of a planar carbon form. The metalized intermediate is then reacted with a tritium donor to covalently label the planar carbon form. The tritiated planar carbon forms produced are useful, for example, for determination of a biological property or environmental fate of planar carbon forms.

Claims (36)

1. A planar carbon form comprising one or more atoms of tritium covalently associated with said planar carbon form, wherein said tritium is present as a component of —CH 2 OH group, wherein at least one of said hydrogens is replaced with tritium, or said tritium is present as

wherein R is any carbon group that results from a reduced ketone in the acyl functionalized intermediate.

2. The planar carbon form of claim 1 wherein said tritiated planar carbon fowl has a tritium specific activity in excess of 0.5 Curies per milliatom.

3. The planar carbon form of claim 1 wherein the planar carbon form is selected from the group carbon nanotube and graphene.

4. The planar carbon form of claim 1 wherein the planar carbon form is a nanotube.

5. The planar carbon form of claim 4 wherein the nanotube is single-walled.

6. The planar carbon form of claim 4 wherein the nanotube is multi-walled.

7. A method for producing the tritiated planar carbon form of claim 1 comprising:

reacting a planar carbon form comprising one or more carboxylic acid groups on a surface of said planar carbon form, with a reducing agent capable of reducing a carboxylic acid so as to produce a tritiated planar carbon form with at least one atom of tritium associated with said surface.

8. The method of claim 7 wherein said reducing agent includes at least one 3 H.

9. The method of claim 7 wherein the reducing agent is selected from the group B 2 3 H 6 and LiAl 3 H 4 .

10. The method of claim 7 wherein said planar carbon form is the group comprising a carbon nanotube and graphene.

11. The method of claim 7 wherein said reducing agent is B 2 3 H 6 wherein said B 2 3 H 6 is formed in situ.

12. The method of claim 7 wherein said reacting is in an organic solvent.

13. The method of claim 12 wherein said organic solvent is tetrahydrofuran.

14. A method for producing the tritiated planar carbon form of claim 1 comprising:

forming a metallated planar carbon form by reacting a planar carbon form with a metal donor under conditions suitable for displacement of a hydrogen on a surface of said planar carbon form; and

reacting said metallated planar carbon form with tritiated water to form a tritiated planar carbon form.

15. The method of claim 14 wherein said forming comprises contacting the planar carbon form with a strong aryl or alkylmetal base along with said metal donor.

16. The method of claim 14 wherein said planar carbon form is metallated with a metal selected from the group lithium, beryllium, magnesium, aluminum, and titanium.

17. The method of claim 14 wherein the planar carbon form is selected from the group carbon nanotube and graphene.

18. The method of claim 14 wherein the metal is Li.

19. A method for producing the tritiated planar carbon form of claim 1 comprising:

reacting an acyl functionalized planar carbon form having a surface with a reducing agent capable of reducing a ketone so as to produce a tritiated planar carbon form with at least one atom of tritium associated with said surface.

20. The method of claim 19 wherein said reducing agent includes at least one 3 H.

21. The method of claim 19 wherein the reducing agent is selected from the group B 2 3 H 6 , LiAl 3 H 4 , and NaB 3 H 4 .

22. The method of claim 19 wherein said planar carbon form is selected from the group carbon nanotube and graphene.

23. The method of claim 19 wherein said reacting is in an organic solvent.

24. The method of claim 23 wherein said organic solvent is tetrahydrofuran.

25. A method of detecting the planar carbon form in a sample comprising:

supplementing a planar carbon form source with the tritiated planar carbon form of claim 1 to produce a labeled source; and

detecting the presence or absence of a planar carbon form in a test sample derived from said labeled source by measuring the presence or absence of a beta particle emission from said sample.

26. The method of claim 25 wherein said sample is selected from the group an environmental sample, an air sample, a soil sample, a manufacturing sample, a medical sample, a biological sample, a plant sample, a tissue sample, and an animal sample.

27. The method of claim 25 , further comprising determining one or more pharmacological characteristics of a biological system from said detecting.

28. The method of claim 27 , wherein said pharmacological characteristic is selected from the group absorption, distribution, metabolism, excretion, and biodistribution.

29. The method of claim 25 wherein the detecting is by subjecting at least a portion of said sample to a method selected from the group liquid scintillation counting and autoradiography.

Assignments (2)
CHANGE OF NAME Recorded Mar 25, 2024
From: PERKINELMER HEALTH SCIENCES, INC.
To: REVVITY HEALTH SCIENCES, INC.
Reel/Frame 067006/0297 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 15, 2011
From: FILER, CRIST N.
To: PERKINELMER HEALTH SCIENCES, INC.
Reel/Frame 026457/0743 →